QuanBio.com
QuanBio is a bio-engineering company developing an AI-powered, non-invasive vascular screening platform called QuanCardio. The platform uses photoplethysmography (PPG) sensors and advanced AI algorithms to provide real-time analysis of over 25 cardiovascular biomarkers, enabling rapid and precise arterial stiffness and vascular health assessments at the point of care. The technology supports early detection of cardiovascular diseases such as peripheral artery disease and coronary artery disease, offering actionable clinical insights to healthcare providers for personalized treatment decisions. QuanBio's solution aims to democratize cardiovascular assessment by making it affordable and accessible, reducing complications and healthcare costs. The platform is under development and not yet approved in the United States, with a strong foundation in scientific research, machine learning, and clinical validation.
QuanBio.com
QuanBio is a bio-engineering company developing an AI-powered, non-invasive vascular screening platform called QuanCardio. The platform uses photoplethysmography (PPG) sensors and advanced AI algorithms to provide real-time analysis of over 25 cardiovascular biomarkers, enabling rapid and precise arterial stiffness and vascular health assessments at the point of care. The technology supports early detection of cardiovascular diseases such as peripheral artery disease and coronary artery disease, offering actionable clinical insights to healthcare providers for personalized treatment decisions. QuanBio's solution aims to democratize cardiovascular assessment by making it affordable and accessible, reducing complications and healthcare costs. The platform is under development and not yet approved in the United States, with a strong foundation in scientific research, machine learning, and clinical validation.